Radiopharmazie

Introduction

The Radiopharmacy department is an integral part of the clinic of nuclear medicine and its

prime responsibility is the preparation of high-quality radiopharmaceuticals, the base for a

high-quality nuclear medicine examination bringing new innovations “from-bench-to-bedside”.

The Radiopharmaceutical Production Facility houses a manufacturing area designed for the

cGMP production and control of radiopharmaceutical agents for translational clinical research

and human clinical use. This facility is staffed by experienced radiochemists in QP position and

CMC experts, responsible for ensuring that the manufactured radiopharmaceuticals are cGMP

compliant.